Klein J O
Pediatr Infect Dis. 1984 May-Jun;3(3 Suppl):S5-8. doi: 10.1097/00006454-198405001-00002.
Bacteremia is a relatively common event in young, apparently mildly ill febrile children. The bacteremia is associated with certain risk factors including age, elevated temperature and high white blood cell count or increased erythrocyte sedimentation rate. The disease and bacteremia clears without antimicrobial agents in some children, but many untreated children have persistent disease. Culture of blood is valuable in children with risk features and may be enhanced in the future as methods for detection of antigen become more widely available. Available data from randomized trials of therapy do not provide clear guidelines for treatment and opinions about optimal management of children at risk for bacteremia vary. My judgement is that presumptive therapy is warranted for the child who is 6 to 24 months of age, who has high fever and has high white blood cell count. Therapy should be effective for the pneumococcus and for H. influenzae. Currently, I recommend amoxicillin or, for children allergic to penicillin, trimethoprim-sulfamethoxazole or cefaclor. After 48 to 72 hours the physician can judge the clinical course and will have data from cultures to base decisions about management of the illness.
菌血症在看似病情轻微发热的幼儿中是较为常见的情况。菌血症与某些危险因素相关,包括年龄、体温升高、白细胞计数升高或红细胞沉降率增加。在一些儿童中,疾病和菌血症在未使用抗菌药物的情况下会自行清除,但许多未经治疗的儿童会持续患病。对于具有风险特征的儿童,血液培养很有价值,随着抗原检测方法的更广泛应用,其价值可能会在未来得到提升。来自治疗随机试验的现有数据并未提供明确的治疗指南,对于菌血症高危儿童的最佳管理意见也各不相同。我的判断是,对于6至24个月大、高热且白细胞计数高的儿童,进行经验性治疗是有必要的。治疗应针对肺炎球菌和流感嗜血杆菌有效。目前,我推荐阿莫西林,对于对青霉素过敏的儿童,推荐使用甲氧苄啶-磺胺甲恶唑或头孢克洛。48至72小时后,医生可以判断临床病程,并将根据培养结果的数据来决定疾病的管理方案。